FDA Posts Final Guidance on REMS Modifications

Drug GMP Report
A A
The FDA has updated its guidance on changes to risk evaluation and mitigation strategies (REMS) with new details on submissions.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00